Product
Desvenlafaxine succinate
Aliases
Desvenlafaxine succinate sustained-release (DVS SR)
Name
Desvenlafaxine
INN Name
Desvenlafaxine Succinate
FDA Approved
Yes
1 clinical trial
14 organizations
3 indications
4 documents
Indication
Major Depressive DisorderIndication
DepressionIndication
MajorClinical trial
A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive DisorderStatus: Completed, Estimated PCD: 2008-02-01
Organization
Preferred Pharmaceuticals Inc.Document
DailyMed Label: DesvenlafaxineOrganization
NuCare Pharmaceuticals,Inc.Organization
Proficient Rx LPOrganization
Breckenridge Pharmaceutical, Inc.Document
DailyMed Label: Desvenlafaxine
Organization
REMEDYREPACK INC. Organization
DIRECT RXOrganization
Greenstone LLCOrganization
Lupin Pharmaceuticals, Inc.Organization
A-S Medication SolutionsOrganization
bryant ranch prepackDocument
DailyMed Label: PristiqOrganization
Preferred Pharmaceuticals Inc. USAOrganization
Preferred Pharmaceutical, Inc.Organization
Alembic Pharmaceuticals Limited